Jeffrey Arnold is executive chairman of First Light Biosciences, president of Arnold Strategies LLC, a strategic advisor to early- and growth-stage CEOs, and an angel investor with Mass. Med. Angels and Boston Harbor Angels. For 20 years, Jeff was a serial healthcare / medical-device CEO of multiple private and public technology and life-science companies. These include Cambridge Heart, a cardiology diagnostics company which he founded and took public; CardioFocus, a VC-backed catheter ablation company; and Accelrys, a public company with software tools for rational drug design, now a division of Dassault Systémes.
Currently, Jeff is an active investor, board member, and advisor to CEOs and business owners helping with strategy, team building, financing, sales, marketing, and exits. He has helped 18 companies raise angel or venture rounds totaling over $100 million and helped multiple companies achieve exits totaling over $1 billion. Jeff is a guest lecturer at the MIT Sloan School, a mentor at the MIT Venture Mentoring Society, on the grant review board of the MIT Deshpande Center, and on the board of overseers at the Museum of Science. He was formerly chairman of the Greater Boston Chapter of the American Heart Association. He received a BSEE from MIT in 1972. He enjoys family, mogul skiing, hiking and mountain climbing, tennis, and sailing.